Intervention Review

Risperidone versus olanzapine for schizophrenia

  1. Mahesh B Jayaram1,*,
  2. Prakash Hosalli2,
  3. T S Stroup3

Editorial Group: Cochrane Schizophrenia Group

Published Online: 17 MAR 2010

Assessed as up-to-date: 9 JAN 2006

DOI: 10.1002/14651858.CD005237.pub2

Database Title

Additional Information

How to Cite

Jayaram MB, Hosalli P, Stroup TS. Risperidone versus olanzapine for schizophrenia. Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD005237. DOI: 10.1002/14651858.CD005237.pub2.

Author Information

  1. 1

    Leeds Partnership Foundation NHS Trust, CMHT, Leeds, UK

  2. 2

    Seacroft Hospital, The Newsam Centre, Leeds, West Yorkshire, UK

  3. 3

    Division of Mental Health Services & Policy Research, New York State Psychiatric Institute, Psychiatry, New York, New York, USA

*Mahesh B Jayaram, CMHT, Leeds Partnership Foundation NHS Trust, Bridge House, Balm Road, Leeds, LS10 2TP, UK. maheshbj@gmail.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 17 MAR 2010

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (59K)Standard (597K)Full (1061K)

  1. Current Version

    Risperidone versus olanzapine for schizophrenia

    Mahesh B Jayaram, Prakash Hosalli and T S Stroup

    Article first published online: 17 MAR 2010 | DOI: 10.1002/14651858.CD005237.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Risperidone versus olanzapine for schizophrenia

    MB Jayaram and P Hosalli

    Article first published online: 25 JAN 2006 | DOI: 10.1002/14651858.CD005237

View Full Article (HTML) Summary (59K)Standard (597K)Full (1061K)